Bacteriostatic Water for Injection Market Size was valued at USD 1.0 Billion in 2022. The Bacteriostatic Water for Injection market industry is projected to grow from USD 1.1 Billion in 2023 to USD 2.0 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.80% during the forecast period (2023 - 2032).The expansion of the biopharmaceutical and generic injectable medication sectors, as well as the enormous number of vendors that have entered this market are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Unlike other single-use sterile water containers, bacteriostatic water containers can be repeatedly reentered with sterile needles to dissolve pharmaceuticals. The market for bacteriostatic water for injection has grown globally as a result of this issue. In addition to being a sterile solution, bacteriostatic water containing benzyl alcohol can also prevent the growth of pathogenic bacteria, which has helped the market for bacteriostatic water for injection expand. Bacteriostatic water can also be used to make injections that will be given via other channels, including intravenous, subcutaneous, and intramuscular routes. The market for bacteriostatic water for injection has expanded quickly in recent years due to its wide range of uses.
One of the main factors propelling the bacteriostatic water for injection market growth is the expansion of the biopharmaceutical and generic injectable medicine sectors. Drug targets are being identified more and more by biotechnology and pharmaceutical businesses that are primarily engaged in the discovery and development of medications to treat common and emerging diseases. Due to the rising prevalence of chronic diseases around the world, pharmaceutical companies are also finding and creating novel medications. In contrast to branded injectable pharmaceuticals, generic injectable drugs are developed more quickly since pharmaceutical companies are not required to do clinical trials and toxicity assessments on these products. The use of generic products has expanded as more vendors enter the worldwide market for injectable generic pharmaceuticals to provide affordable substitutes for branded goods.
Due to specific undeniable realities, such as the growing population and number of sick individuals, the pharmaceutical sector is growing year over year. An organization's need for raw materials and production capacity rises as it expands. Water is utilized in the pharmaceutical business for cleaning and medication manufacturing, and water for injection must adhere to strict quality requirements defined in several pharmacopeias. As a result, the pharmaceutical industry is experiencing an increase in demand for process equipment, water treatment systems, and bacteriostatic water for injection. As a result of technological developments like membrane separation, irradiation, nanoparticle diagnosis, bioaugmentation, and hybrid technology, access to bacteriostatic water for injection is anticipated to increase. This will result in the expansion of small and medium enterprise (SME) roles in the pharmaceutical industry, particularly in cities of populous countries like India and China. Thus, driving the Bacteriostatic Water for Injection market revenue.
The Bacteriostatic Water for Injection market segmentation, based on application, includes medication dilution, clinical pharmacology, and anti-bacterial applications. Medication dilution segment dominated the market in 2022. This is because people are using more injections to take their medications.
The Bacteriostatic Water for Injection market segmentation, based on distribution channel, includes hospital pharmacies, online pharmacies, and others. Hospital pharmacies segment dominated the bacteriostatic water for injection market in 2022.This is because hospital pharmacies are using more bacteriostatic water for injection.
The Bacteriostatic Water for Injection market segmentation, based on end user, includes hospitals, clinics, and others. Hospitals segment dominated the market in 2022. It is attributed to the rising use of medications and injections in the healthcare industry.
Figure 1: Bacteriostatic Water for Injection Market, by End User, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Bacteriostatic Water for Injection Market dominated this market in 2022 (45.80%). The US healthcare market is the biggest in the world in terms of size and is one of the most promising markets for bacteriostatic water for injection. It is also anticipated that it will continue to rank among the top markets during the course of the projected period as a result of the usage of cutting-edge technology, the expansion of research and development facilities, and the rising consumer demand. Further, the U.S. Bacteriostatic Water for Injection market held the largest market share, and the Canada Bacteriostatic Water for Injection market was the fastest growing market in the North America region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: BACTERIOSTATIC WATER FOR INJECTION MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Bacteriostatic Water for Injection market is expected to register significant growth from 2023 to 2032. Over the projected period, the bacteriostatic water for injection market will increase in Europe due to rising pharmaceutical expenditures overall and per capita. Further, the German Bacteriostatic Water for Injection market held the largest market share, and the U.K Bacteriostatic Water for Injection market was the fastest growing market in the European region.
The Asia Pacific Bacteriostatic Water for Injection market accounted for the healthy market share in 2022. The region’s aging population, expanding middle class, rising earnings, and urbanization are all contributing to the pharmaceutical market's rapid growth. One of the world's largest pharmaceutical industries is found in China. Generic pharmaceuticals, therapeutic drugs, active pharmaceutical ingredients, and traditional Chinese medicine are all produced in the country. The majority of the country's registered medications are generic. This will result in a rise in demand for bacteriostatic water for injection from the country's pharmaceutical industry.Moreover, China’s Bacteriostatic Water for Injection market held the largest market share, and the Indian Bacteriostatic Water for Injection market was the fastest growing market in the Asia-Pacific region.
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Bacteriostatic Water for Injection market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Bacteriostatic Water for Injection Industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Bacteriostatic Water for Injection Industry to benefit clients and increase the market sector. In recent years, the Bacteriostatic Water for Injection Industry has offered some of the most significant advantages to medicine. Major players in the Bacteriostatic Water for Injection market, including Acella Pharmaceuticals, LLC, Merck KGaA, Abbott Laboratories, Procter and Gamble, Pfizer, Inc., Reckitt Benckiser Group PLC, Novartis AG, GlaxoSmithKline PLC, Sanofi, and Johnson and Johnson Services, Inc., are attempting to increase market demand by investing in research and development operations.
A biopharmaceutical firm called Merck & Co Inc (Merck) is dedicated to the discovery, development, production, and marketing of prescription drugs, biologic therapies, vaccines, and animal health products. It provides products on prescription for the treatment of conditions like diabetes, cancer, immunological diseases, cardiovascular disease, and cancer. The business offers vaccinations, poultry, cattle, and aquaculture products, among other animal health items. Merck provides managed healthcare services to hospitals, government organizations, wholesalers, retailers, and hospitals.
It also provides veterinarians, distributors, and animal producers with animal health products. Operating in the Americas, Europe, the Middle East, Africa, Asia Pacific, and Latin America are the company and its subsidiaries. Outside of North America and Canada, Merck is known as MSD, and its headquarters are in Kenilworth, New Jersey. Merck introduced the Milli-Q IQ 7000 system in March 2017. The device is a water purifying invention from the seventh generation of Milli-Q. This system is the first to employ mercury-free, environmentally beneficial UV lights. The system's ergonomic layout and compact size decrease waste, hasten research, and boost production.
A wide variety of healthcare goods are discovered, developed, produced, and sold by Abbott Laboratories (Abbott), including branded generic medications, diagnostic tools and procedures, and infant, child, and adult nutritional supplements. The business also sells a range of medical devices, such as those for neuromodulation, electrophysiology, rhythm control, vascular and structural cardiac devices, and heart failure. The business also sells dietary supplements, minerals, and nutrition goods. It runs manufacturing plants all around the world and has research and development centers in the US, China, Colombia, India, Singapore, Spain, and the UK. The corporation sells its goods across Africa, the Middle East, Latin America, North America, and the Asia-Pacific region. The US city of Abbott Park, Illinois, is home to Abbott.
Key Companies in the Bacteriostatic Water for Injection Market Include
Acella Pharmaceuticals, LLC
Merck KGaA
Abbott Laboratories
Procter and Gamble
Pfizer, Inc.
Reckitt Benckiser Group PLC
Novartis AG
GlaxoSmithKline PLC
Sanofi
Johnson and Johnson Services, Inc.
Bacteriostatic Water for Injection Industry Developments
April 2020:The COVID-19 Treatment Acceleration Program (CTAP) was started by the US Food and pharmacological Administration (US FDA) in order to approve new therapies and carry out pharmacological trials for COVID-19.
September 2021:Two facilities in Argentina and Brazil have been chosen by the Pan American Health Organization (PAHO) to serve as regional hubs for the development and production of COVID-19 vaccines based on messenger ribonucleic acid (mRNA).
July 2021:Potassium chloride in water for injection was first made available by Nexus Pharmaceuticals in single-dose IV bags containing 10mEq/100mL, 10mEq/50mL, and 20mEq/50mL. When oral replacement is not an option, potassium chloride injection is used to address deficiency.
Medication Dilution
Clinical Pharmacology
Anti-bacterial Applications
Hospital Pharmacies
Online Pharmacies
Others
Hospitals
Clinics
Others
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Australia
Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
| Report Attribute/Metric | Details |
| Market Distribution Channel 2022 | USD 1.0 Billion |
| Market Distribution Channel 2023 | USD 1.1 Billion |
| Market Distribution Channel 2032 | USD 2.0 Billion |
| Compound Annual Growth Rate (CAGR) | 7.80% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Application, Distribution Channel, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Acella Pharmaceuticals, LLC, Merck KGaA, Abbott Laboratories, Procter and Gamble, Pfizer, Inc., Reckitt Benckiser Group PLC, Novartis AG, GlaxoSmithKline PLC, Sanofi, and Johnson and Johnson Services, Inc. |
| Key Market Opportunities | The increase in the development of new drugs and vaccines |
| Key Market Dynamics | The growth of the biopharmaceutical and generic injectable drugs industries and large number of vendors entering the generic injectable drugs industry |
Bacteriostatic Water for Injection Market Highlights:
Frequently Asked Questions (FAQ) :
The Bacteriostatic Water for Injection market Distribution Channel was valued at USD 1.0 Billion in 2022.
The market is projected to grow at a CAGR of 7.80% during the forecast period, 2023-2032.
North America had the largest share in the market
The key players in the market are Acella Pharmaceuticals, LLC, Merck KGaA, Abbott Laboratories, Procter and Gamble, Pfizer, Inc., Reckitt Benckiser Group PLC, Novartis AG, GlaxoSmithKline PLC, Sanofi, and Johnson and Johnson Services, Inc.
The Medication Dilution Application dominated the market in 2022.
The Hospital Pharmacies Distribution Channel had the largest share in the market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
